These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 8796133

  • 41. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA, Chin E, Bondy CA.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
    [Abstract] [Full Text] [Related]

  • 42. Insulin-like growth factor binding protein 1 (IGFBP-1) levels in Turner syndrome.
    Cianfarani S, Holly JM, Pasquino AM, Vaccaro F, Spadoni GL, Bernardini S, Segni M, Boscherini B.
    Horm Metab Res; 1992 Nov; 24(11):537-40. PubMed ID: 1280613
    [Abstract] [Full Text] [Related]

  • 43. Insulin-like growth factor I and its binding proteins 3 and 4 are increased in Human inflammatory synovial fluid.
    Kanety H, Shimon I, Ehrenfeld M, Israeli A, Pariente C, Karasik A.
    J Rheumatol; 1996 May; 23(5):815-8. PubMed ID: 8724290
    [Abstract] [Full Text] [Related]

  • 44. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche.
    Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2283-8. PubMed ID: 9215308
    [Abstract] [Full Text] [Related]

  • 45. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the pubertal growth spurt in the female rhesus monkey.
    Ulijaszek SJ.
    Am J Phys Anthropol; 2002 May; 118(1):77-85. PubMed ID: 11953947
    [Abstract] [Full Text] [Related]

  • 46. Insulin-like growth factor-I (IGF-I) serum concentrations in healthy children and adolescents: relationship to level of contamination by DDT-derivative pesticides.
    Zumbado M, Luzardo OP, Lara PC, Alvarez-León EE, Losada A, Apolinario R, Serra-Majem L, Boada LD.
    Growth Horm IGF Res; 2010 Feb; 20(1):63-7. PubMed ID: 19699127
    [Abstract] [Full Text] [Related]

  • 47. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM, Daly F, Holly JM, Hughes SC, Camacho-Hübner C, Abdulla AF, Gale EA, Savage MO.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [Abstract] [Full Text] [Related]

  • 48. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A, Lang CH, Blethen SL, Ng LC, Wilson TA.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [Abstract] [Full Text] [Related]

  • 49. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A, Bini V, Cabiati G, Papi F, Arzano S, Celi F, Sanasi M.
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.
    Frystyk J, Grønbaek H, Skjaerbaek C, Flyvbjerg A, Orskov H, Baxter RC.
    Endocrinology; 1998 Oct; 139(10):4286-92. PubMed ID: 9751511
    [Abstract] [Full Text] [Related]

  • 54. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
    Tally M, Eriksson U, Thorén M, Brismar K, Hall K.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
    [Abstract] [Full Text] [Related]

  • 55. Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus.
    Knip M, Tapanainen P, Pekonen F, Blum WF.
    Eur J Endocrinol; 1995 Oct; 133(4):440-4. PubMed ID: 7581967
    [Abstract] [Full Text] [Related]

  • 56. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M, Uemasu J, Kawasaki H.
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [Abstract] [Full Text] [Related]

  • 57. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis.
    Neidel J.
    Clin Exp Rheumatol; 2001 Jun; 19(1):81-4. PubMed ID: 11247331
    [Abstract] [Full Text] [Related]

  • 58. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
    Shishko PI, Dreval AV, Abugova IA, Zajarny IU, Goncharov VC.
    Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
    [Abstract] [Full Text] [Related]

  • 59. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO, Dunger DB.
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [Abstract] [Full Text] [Related]

  • 60. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
    Sorensen JS, Birkebaek NH, Bjerre M, Pociot F, Kristensen K, Hoejberg AS, Frystyk J, Danish Society for Diabetes in Childhood and Adolescence.
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.